PRTG Annual Total Long Term Liabilities
$1.57 M
-$20.30 M-92.82%
31 March 2024
Summary:
As of January 23, 2025, PRTG annual total long term liabilities is $1.57 million, with the most recent change of -$20.30 million (-92.82%) on March 31, 2024. During the last 3 years, it has fallen by -$22.48 million (-93.47%). PRTG annual total long term liabilities is now -94.48% below its all-time high of $28.45 million, reached on March 31, 2022.PRTG Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTG Quarterly Long Term Liabilities
$1.14 M
+$716.00 K+169.67%
30 September 2024
Summary:
As of January 23, 2025, PRTG quarterly total long term liabilities is $1.14 million, with the most recent change of +$716.00 thousand (+169.67%) on September 30, 2024. Over the past year, it has dropped by -$13.86 million (-92.41%). PRTG quarterly long term liabilities is now -97.15% below its all-time high of $39.96 million, reached on December 31, 2022.PRTG Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTG Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -92.8% | -92.4% |
| 3 y3 years | -93.5% | -96.0% |
| 5 y5 years | -93.3% | -95.1% |
PRTG Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -94.5% | at low | -97.2% | +169.7% |
| 5 y | 5-year | -94.5% | at low | -97.2% | +169.7% |
| alltime | all time | -94.5% | -97.2% |
Portage Biotech Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.14 M(+169.7%) |
| June 2024 | - | $422.00 K(-73.1%) |
| Mar 2024 | $1.57 M(-92.8%) | $1.57 M(-89.5%) |
| Dec 2023 | - | $15.00 M(-32.6%) |
| Sept 2023 | - | $22.27 M(-3.5%) |
| June 2023 | - | $23.08 M(+5.5%) |
| Mar 2023 | $21.87 M(-23.1%) | $21.87 M(-45.3%) |
| Dec 2022 | - | $39.96 M(+7.2%) |
| Sept 2022 | - | $37.28 M(+44.0%) |
| June 2022 | - | $25.89 M(-9.0%) |
| Mar 2022 | $28.45 M(+18.3%) | $28.45 M(+20.5%) |
| Dec 2021 | - | $23.61 M(+0.4%) |
| Sept 2021 | - | $23.51 M(-2.7%) |
| June 2021 | - | $24.17 M(+0.5%) |
| Mar 2021 | $24.05 M(-3.7%) | $24.05 M(+11.3%) |
| Dec 2020 | - | $21.60 M(0.0%) |
| Sept 2020 | - | $21.60 M(-13.7%) |
| June 2020 | - | $25.02 M(+0.2%) |
| Mar 2020 | $24.96 M(+6.9%) | $24.96 M(+3.9%) |
| Dec 2019 | - | $24.02 M(+2.8%) |
| Sept 2019 | - | $23.36 M(0.0%) |
| June 2019 | - | $23.36 M(0.0%) |
| Mar 2019 | $23.36 M(>+9900.0%) | $23.36 M(>+9900.0%) |
| Dec 2018 | - | $216.00 K(+0.9%) |
| Sept 2018 | - | $214.00 K(-17.7%) |
| June 2018 | - | $260.00 K(+11.6%) |
| Mar 2018 | $233.00 K(+15.9%) | $233.00 K(-9.0%) |
| Dec 2017 | - | $256.00 K(+0.8%) |
| Sept 2017 | - | $254.00 K(+0.8%) |
| June 2017 | - | $252.10 K(+25.4%) |
| Mar 2017 | $201.00 K(>+9900.0%) | $201.00 K(>+9900.0%) |
| Dec 2016 | - | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) |
| June 2016 | - | $0.00(0.0%) |
| Mar 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2015 | - | $0.00(0.0%) |
| Sept 2015 | - | $0.00(0.0%) |
| June 2015 | - | $0.00(0.0%) |
| Mar 2015 | $0.00 | $0.00(0.0%) |
| Dec 2014 | - | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | - | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | - | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) |
| Mar 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | - | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) |
| Mar 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | - | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) |
| Mar 2010 | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2009 | - | $3.02 M(>+9900.0%) |
| Sept 2009 | - | $0.00(0.0%) |
| June 2009 | - | $0.00(0.0%) |
| Mar 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2008 | - | $0.00(0.0%) |
| Sept 2008 | - | $0.00(0.0%) |
| Mar 2008 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2007 | - | $0.00(0.0%) |
| Mar 2007 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2006 | - | $0.00(0.0%) |
| June 2006 | - | $0.00(0.0%) |
| Mar 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2004 | - | $0.00(0.0%) |
| June 2003 | - | $0.00(0.0%) |
| Dec 2002 | - | $0.00(0.0%) |
| June 2002 | - | $0.00(0.0%) |
| Mar 2002 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2001 | - | $0.00(0.0%) |
| Sept 2001 | - | $0.00(0.0%) |
| Dec 2000 | - | $0.00 |
| Mar 2000 | $0.00(0.0%) | - |
| Mar 1999 | $0.00(0.0%) | - |
| Mar 1998 | $0.00 | - |
FAQ
- What is Portage Biotech annual total long term liabilities?
- What is the all time high annual total long term liabilities for Portage Biotech?
- What is Portage Biotech annual total long term liabilities year-on-year change?
- What is Portage Biotech quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Portage Biotech?
- What is Portage Biotech quarterly long term liabilities year-on-year change?
What is Portage Biotech annual total long term liabilities?
The current annual total long term liabilities of PRTG is $1.57 M
What is the all time high annual total long term liabilities for Portage Biotech?
Portage Biotech all-time high annual total long term liabilities is $28.45 M
What is Portage Biotech annual total long term liabilities year-on-year change?
Over the past year, PRTG annual total long term liabilities has changed by -$20.30 M (-92.82%)
What is Portage Biotech quarterly total long term liabilities?
The current quarterly long term liabilities of PRTG is $1.14 M
What is the all time high quarterly long term liabilities for Portage Biotech?
Portage Biotech all-time high quarterly total long term liabilities is $39.96 M
What is Portage Biotech quarterly long term liabilities year-on-year change?
Over the past year, PRTG quarterly total long term liabilities has changed by -$13.86 M (-92.41%)